K.J. Harrison & Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.26M Hold
10,000
– – 0.31% 91
2026
Q2
$2.16M Hold
10,000
– – 0.31% 88
2026
Q1
$1.83M Hold
10,000
– – 0.3% 84
2025
Q4
$1.76M Sell
10,000
-6
-0.1% -$980 0.23% 112
2025
Q3
$1.55M Buy
+10,006
New +$1.35M 0.22% 111

Other funds holding BIIB

K.J. Harrison & Partners's BIIB Position: Q3 2026 in Review

K.J. Harrison & Partners held its Biogen (BIIB) position steady in Q3 2026 at 10,000 shares worth $2.26M. The position accounts for 0.31% of the portfolio, ranked #91.

K.J. Harrison & Partners first reported a position in BIIB in Q3 2025 and has held it in 5 quarters since. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • K.J. Harrison & Partners held 10,000 shares of Biogen worth $2.26M as of Q3 2026.
  • K.J. Harrison & Partners left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.31% of K.J. Harrison & Partners's portfolio in Q3 2026, its #91 holding.
  • K.J. Harrison & Partners first reported a position in Biogen in Q3 2025 and has held it in 5 quarters since.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on K.J. Harrison & Partners's 13F filing for Q3 2026, filed 12 Nov 2026.